“…These results, in part, agree with Mathalon et al (2000) that P3a and P3b tracked illness duration longitudinally or across different stages of illnesses (Jahshan et al, 2012a). However, when examining data longitudinally, we found that patients already showed impairment at baseline and this deficit was stable over time, similar to previous reports (del Hermens et al, 2010;Jahshan et al, 2012a;Kruiper et al, 2018;Morales-Muñoz et al, 2017). A similar pattern of results was found with P3a amplitude, suggesting P3a deficits are already present at a first episode, substantiating other reports (Brown et al, 2002;de Wilde et al, 2008;del Re et al, 2015;Demiralp et al, 2002;Devrim-Üçok et al, 2016Devrim-Üçok et al, , 2006Hirayasu et al, 1998;Kruiper et al, 2018;Morales-Muñoz et al, 2017;Renoult et al, 2007;Salisbury et al, 1998;Sumich et al, 2006;Umbricht et al, 2006).…”